Your browser doesn't support javascript.
loading
Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy.
Taghvaei, Raheleh; Zadeh, Mahdi Zirakchian; Sirous, Reza; Shamchi, Sara Pourhassan; Raynor, William Y; Seraj, Siavash Mehdizadeh; Moghbel, Mateen; Wang, Shiyu; Werner, Thomas J; Zhuang, Hongming; Alavi, Abass.
Afiliación
  • Taghvaei R; Department of Radiology, Hospital of The University of Pennsylvania PA, USA.
  • Zadeh MZ; Department of Radiology, Hospital of The University of Pennsylvania PA, USA.
  • Sirous R; Department of Radiology, Children's Hospital of Philadelphia PA, USA.
  • Shamchi SP; University of Maryland Medical Center Baltimore, MD, USA.
  • Raynor WY; Department of Radiology, Hospital of The University of Pennsylvania PA, USA.
  • Seraj SM; Department of Radiology, Hospital of The University of Pennsylvania PA, USA.
  • Moghbel M; Drexel University College of Medicine Philadelphia, PA, USA.
  • Wang S; Department of Radiology, Hospital of The University of Pennsylvania PA, USA.
  • Werner TJ; Department of Radiology, Stanford University Medical Center Stanford, CA, USA.
  • Zhuang H; Department of Dermatology, Hospital of The University of Pennsylvania PA, USA.
  • Alavi A; Department of Radiology, Hospital of The University of Pennsylvania PA, USA.
Am J Nucl Med Mol Imaging ; 8(6): 407-414, 2018.
Article en En | MEDLINE | ID: mdl-30697460
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Nucl Med Mol Imaging Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Nucl Med Mol Imaging Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos